Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1.
DNA vaccines encoding the human papillomavirus type-16 (HPV-16) E6 and E7 oncoproteins genetically fused to the human herpes simplex virus type 1 (HSV-1) gD protein were tested in mice for induction of T cell-mediated immunity and protection against tumor cell challenge. Hybrid genes, generated afte...
主要な著者: | Lasaro, M, Diniz, M, Reyes-Sandoval, A, Ertl, H, Ferreira, L |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2005
|
類似資料
-
Identification of High-Risk Human Papillomavirus DNA, p16, and E6/E7 Oncoproteins in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas
著者:: Andrejs Lifsics, 等
出版事項: (2021-05-01) -
Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation
著者:: Kerry Dust, 等
出版事項: (2022-08-01) -
Human papillomavirus type 16 oncoproteins as immune modulators and immune tragets /
著者:: Khairunadwa Jemon, author, 等
出版事項: (2012) -
The Efficacy of Therapeutic DNA Vaccines Expressing the Human Papillomavirus E6 and E7 Oncoproteins for Treatment of Cervical Cancer: Systematic Review
著者:: Ayazhan Akhatova, 等
出版事項: (2021-12-01) -
Herpes Simplex Virus and Human Papillomavirus Coinfections in Hyperimmunoglobulin E Syndrome Presenting as a Conjunctival Mass Lesion
著者:: Mitra Akbari, 等
出版事項: (2017-01-01)